Passage Bio Inc (PASG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 14,270 | 20,702 | 17,378 | 18,050 | 18,446 |
| Operating Income | -14,270 | -20,702 | -17,378 | -18,050 | -18,446 |
| Other Income | 1,545 | 1,362 | 1,387 | 1,339 | 1,688 |
| Pre-tax Income | -12,725 | -19,340 | -15,991 | -16,711 | -16,758 |
| Net Income Continuous | -12,725 | -19,340 | -15,991 | -16,711 | -16,758 |
| Net Income | $-12,725 | $-19,340 | $-15,991 | $-16,711 | $-16,758 |
| EPS Basic Total Ops | -3.80 | -6.15 | -5.09 | -6.00 | -6.00 |
| EPS Basic Continuous Ops | -3.86 | -6.15 | -5.09 | -5.94 | -6.09 |
| EPS Diluted Total Ops | -3.80 | -6.15 | -5.09 | -6.00 | -6.00 |
| EPS Diluted Continuous Ops | -3.86 | -6.15 | -5.09 | -5.94 | -6.09 |
| EPS Diluted Before Non-Recurring Items | -4.00 | -6.20 | -5.20 | N/A | N/A |
| EBITDA(a) | $-13,916 | $-20,364 | $-16,878 | $-17,688 | $-18,487 |